Thackeray James T, Beanlands Rob S, Dasilva Jean N
Cardiovascular PET Molecular Imaging Program, National Cardiac PET Centre, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
J Nucl Med. 2007 Oct;48(10):1733-40. doi: 10.2967/jnumed.107.043570. Epub 2007 Sep 14.
(11)C-meta-Hydroxyephedrine (HED) is used in cardiac PET as an index of norepinephrine (NE) reuptake transporter (NET) density and synaptic NE levels. Whereas cardiac uptake is well documented, tracer retention in other tissues with rich noradrenergic innervation is unclear. Dysfunctional sympathetic nervous system (SNS) function in extracardiac metabolic storage tissues (i.e., adipose tissue and skeletal muscle) and endocrine organs contributes to several disorders. The aim of this study was to determine the potential of HED as an index of NE function in brown adipose tissue, lung, pancreas, skeletal muscle, and kidney by identifying NET-specific retention and determining the presence of radiolabeled metabolites.
Male Sprague-Dawley rats were administered HED and sacrificed at 30 min after tracer injection. Tissues were rapidly excised and counted for radioactivity, and relative tracer retention was quantified. Pretreatment with NET inhibitors established specific HED accumulation. The effect of elevated NE was tested by subcutaneous minipump NE infusion or inhibition of monoamine oxidase. Column-switch high-performance liquid chromatography (HPLC) was used to analyze the presence of radiolabeled metabolites in heart, brown adipose tissue, pancreas, and plasma.
NET-specific retention was observed in heart, brown adipose tissue, lung, and pancreas but not in liver, skeletal muscle, or kidney. A dose-dependent response of HED accumulation to treatments elevating NE levels was established in tissues exhibiting specific uptake. At 30 min after tracer administration, HPLC analysis revealed 93%-95% of total radioactivity signal derived from unchanged HED in heart, pancreas, and brown adipose tissue compared with 61% +/- 8% unchanged HED in plasma.
In addition to the heart, lung, pancreas, and brown adipose tissue exhibit specific and NE-responsive uptake of HED, supporting the potential for novel PET studies of SNS integrity in these tissues.
(11)C-间羟基麻黄碱(HED)在心脏正电子发射断层显像(PET)中用作去甲肾上腺素(NE)再摄取转运体(NET)密度和突触NE水平的指标。虽然心脏摄取已有充分记录,但该示踪剂在其他去甲肾上腺素能神经支配丰富的组织中的滞留情况尚不清楚。心脏外代谢储存组织(即脂肪组织和骨骼肌)及内分泌器官中功能失调的交感神经系统(SNS)功能与多种疾病有关。本研究的目的是通过识别NET特异性滞留并确定放射性标记代谢物的存在,来确定HED作为棕色脂肪组织、肺、胰腺、骨骼肌和肾脏中NE功能指标的潜力。
给雄性Sprague-Dawley大鼠注射HED,并在注射示踪剂后30分钟处死。迅速切除组织并计数放射性,对相对示踪剂滞留进行定量。用NET抑制剂预处理可确定HED的特异性蓄积。通过皮下微型泵输注NE或抑制单胺氧化酶来测试NE升高的影响。采用柱切换高效液相色谱(HPLC)分析心脏、棕色脂肪组织、胰腺和血浆中放射性标记代谢物的存在情况。
在心脏、棕色脂肪组织、肺和胰腺中观察到NET特异性滞留,但在肝脏、骨骼肌或肾脏中未观察到。在表现出特异性摄取的组织中,建立了HED蓄积对升高NE水平治疗的剂量依赖性反应。在示踪剂给药后30分钟,HPLC分析显示心脏、胰腺和棕色脂肪组织中总放射性信号的93%-95%来自未变化的HED,而血浆中未变化的HED为61%±8%。
除心脏外,肺、胰腺和棕色脂肪组织也表现出对HED的特异性和NE反应性摄取,支持了对这些组织中SNS完整性进行新型PET研究的潜力。